Skip to Content
MilliporeSigma
  • Characterization of cefalexin degradation capabilities of two Pseudomonas strains isolated from activated sludge.

Characterization of cefalexin degradation capabilities of two Pseudomonas strains isolated from activated sludge.

Journal of hazardous materials (2014-07-30)
Bokun Lin, Jinling Lyu, Xian-jin Lyu, Han-qing Yu, Zhong Hu, James C W Lam, Paul K S Lam
ABSTRACT

Pharmaceuticals have recently been regarded as contaminants of emerging concern. To date, there is limited knowledge about antibiotic-degrading microorganisms in conventional activated sludge treatment systems and their characteristics toward antibiotic degradation especially in the presence of a pharmaceutical mixture. As such, antibiotic-degrading microorganisms were investigated and isolated from the activated sludge, and their degradation capabilities were evaluated. Two strains of cefalexin-degrading bacteria CE21 and CE22 were isolated and identified as Pseudomonas sp. in the collected activated sludge. Strain CE22 was able to degrade over 90% of cefalexin, while CE21 was able to remove 46.7% of cefalexin after incubation for 24h. The removal efficiency of cefalexin by CE22, different from that of CE21, was not significantly affected by an increase in cefalexin concentration, even up to 10ppm, however the presence of 1ppm of other pharmaceuticals had a significant effect on the degradation of cefalexin by CE22, but no significant effect on CE21. The degradation product of cefalexin by the two strains was identified to be 2-hydroxy-3-phenyl pyrazine. Our results also indicated that CE21 and CE22 were able to degrade caffeine, salicylic acid and chloramphenicol. Moreover, CE21 was found to be capable of eliminating sulfamethoxazole and naproxen.

MATERIALS
Product Number
Brand
Product Description

Salicylic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Salicylic acid, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
USP
Carbamazepine, United States Pharmacopeia (USP) Reference Standard
USP
Erythromycin, United States Pharmacopeia (USP) Reference Standard
Supelco
Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Melting point standard 235-237°C, analytical standard
Supelco
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Salicylic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ibuprofen, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Ibuprofen
Sigma-Aldrich
Ibuprofen, ≥98% (GC)
Sigma-Aldrich
Erythromycin, tested according to Ph. Eur.
Roxithromycin, European Pharmacopoeia (EP) Reference Standard
Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard
Ibuprofen, European Pharmacopoeia (EP) Reference Standard
Caffeine for system suitability, European Pharmacopoeia (EP) Reference Standard
Ibuprofen for peak identification, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Tetracycline, 98.0-102.0% (HPLC)
Sigma-Aldrich
Salicylic acid, puriss. p.a., ≥99.0% (T)
Sigma-Aldrich
N-Acetyl-D-penicillamine, for HPLC derivatization, ≥99.0% (T)
Sigma-Aldrich
Salicylic acid, ≥99%, FG
Sigma-Aldrich
Erythromycin standard solution, 1 mg/mL in H2O
Sigma-Aldrich
Carbamazepine, powder
Sigma-Aldrich
Tetracycline, 98.0-102.0% (HPLC)
Sigma-Aldrich
Salicylic acid, suitable for plant cell culture
Sigma-Aldrich
Ibuprofen, meets USP testing specifications
Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Sigma-Aldrich
Carbamazepine, meets USP testing specifications
Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
Sigma-Aldrich
Erythromycin, meets USP testing specifications